Kai-Yue Cao

Title: Innovations in Cancer Treatment by Inventor Kai-Yue Cao

Introduction

Kai-Yue Cao is a notable inventor based in Macau, CN. He has made significant contributions to the field of cancer treatment through his innovative research and patent developments. His work focuses on utilizing nucleic acid molecules to combat cancer, showcasing the potential of biotechnology in medical applications.

Latest Patents

Kai-Yue Cao holds a patent for "Nucleic acid molecules and uses thereof." This patent describes a method of treating subjects suffering from cancer by administering an effective amount of double-stranded RNA molecules. The RNA molecules are isolated or derived from bacteria of the genus. The patent also outlines a method for inhibiting the growth or proliferation of cancer cells by contacting them with the RNA molecule. Additionally, it includes a pharmaceutical composition for treating cancer that comprises the RNA molecule and a pharmaceutically tolerable excipient, as well as a double-stranded RNA molecule and a recombinant vector containing the double-stranded RNA molecule.

Career Highlights

Kai-Yue Cao is affiliated with the Macau University of Science and Technology, where he conducts his research and development activities. His work has garnered attention for its innovative approach to cancer treatment, emphasizing the importance of molecular biology in developing effective therapies.

Collaborations

Some of his notable coworkers include Zhi-Hong Jiang and Yu Pan, who contribute to the collaborative research efforts in the field of cancer treatment.

Conclusion

Kai-Yue Cao's innovative work in developing nucleic acid-based treatments for cancer represents a significant advancement in medical science. His contributions highlight the potential of biotechnology to provide new solutions for complex health challenges.